Related Experiment Video
Updated: Feb 5, 2026

07:59
A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
Published on: March 25, 2014
15.6K
Utilizing TAPBPR to promote exogenous peptide loading onto cell surface MHC I molecules
F Tudor Ilca1, Andreas Neerincx1, Mark R Wills2
1Department of Pathology, University of Cambridge, CB2 1QP Cambridge, United Kingdom.
Summary
Researchers developed new methods to study TAPBPR, a peptide editor for MHC I molecules. These systems allow for targeted peptide loading onto cells, potentially enhancing anti-tumor immunity.
Area of Science:
- Immunology
- Molecular Biology
- Cell Biology
Background:
- The presentation of peptides by MHC class I (MHC I) molecules is crucial for adaptive immunity.
- Intracellular peptide editors, including tapasin and TAP-binding protein related (TAPBPR), regulate the MHC I peptide repertoire.
- Existing cell-free assays provide insights but may not fully reflect physiological conditions.
Purpose of the Study:
- To develop physiological systems for assessing TAPBPR-mediated peptide editing on MHC I.
- To investigate the function of membrane-associated and soluble TAPBPR in peptide exchange on cell surface MHC I.
- To explore the therapeutic potential of manipulating MHC I peptide loading.
Main Methods:
- Targeting TAPBPR to the plasma membrane to assess its function in situ.
- Utilizing exogenous soluble TAPBPR added to intact cells.
- Measuring T cell receptor engagement, IFN-γ secretion, and T cell-mediated killing following peptide loading.
Main Results:
- Membrane-associated TAPBPR effectively catalyzes peptide exchange on surface MHC I.
- Soluble TAPBPR also functions as an efficient peptide editor on surface MHC I.
- Both systems enabled the display of immunogenic peptides, leading to T cell activation and target cell killing.
Conclusions:
- Established two novel physiological systems to study TAPBPR-mediated peptide exchange on MHC class I.
- Demonstrated the ability to bypass natural antigen presentation pathways for targeted peptide loading.
- Highlighted the potential therapeutic application of TAPBPR in cancer immunotherapy by enhancing tumor immunogenicity.
More Related Videos
Related Concept Videos
Peptide Bonds
83.1K
A peptide bond covalently attaches amino acids through a dehydration reaction. One amino acid's carboxyl group and another amino acid's amino group combine, releasing a water molecule. The resulting bond is the peptide bond. The products that such linkages form are peptides. As more amino acids join this growing chain, the resulting chain is a polypeptide. Each polypeptide has a free amino group at one end. This end has the N-terminal, or the amino-terminal, and the other end has a free...
83.1K
The Eukaryotic Promoter Region
18.8K
The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences. The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...
18.8K
The Eukaryotic Promoter Region
4.0K
4.0K
Cell-surface Signaling
54.5K
Hormones—or any molecule that binds to a receptor, known as a ligand—that are lipid-insoluble (water-soluble) are not able to diffuse across the cell membrane. In order to be able to affect a cell without entering it, these hormones bind to receptors on the cell membrane. When a first messenger, a hormone, binds to a receptor, a signal cascade is set off, causing second messengers, proteins inside the cell, to become activated, resulting in downstream effects.
54.5K
Immunoglobulin-like Cell Adhesion Molecules
4.4K
Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
4.4K
Positive Regulator Molecules
136.4K
To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
136.4K

